New research indicates that people who come off new GLP-1 drugs like Wegovy and Mounjaro can put back on lost weight far faster than those who stop traditional diet and exercise plans.
Findings released in a major medical journal shows that while overweight people frequently drop about a fifth of their total mass while on the medication, the weight comes back at an estimated rate of nearly a kilo each month once they quit.
"Individuals buying such medications must be aware of the danger of fast weight regain when the medication concludes," stated expert Dr. Susan Jebb.
This pace of regain suggests a reversion to pre-treatment mass in about 18 months.
Analyzing Treatments
The research, which looked at dozens of studies involving thousands of patients, compared the results of GLP-1 agonists with older methods.
Researchers point out that people who shed pounds through diet and exercise typically have a slower weight regain—approximately 0.1 kg a month—once they finish.
Explaining the Rapid Rebound
Experts suggest the way of the injections accounts for the accelerated weight return.
The injections copy a natural hormone called GLP-1, which moderates hunger.
"Artificially providing GLP-1 concentrations several times higher than the body's typical production might result in the system to produce less of its own natural hormone, and could lessen sensitivity to its effects," noted Dr. Adam Collins, a nutrition researcher.
"Withdrawal of this medication means hunger is uncontrolled, making overeating a significant risk."
A Lifelong Condition?
Health authorities advise the injections for individuals with obesity-related medical conditions, accompanied by recommended diet and exercise modifications.
A number of clinicians contend that, given the likelihood of relapse, the therapy might need to be ongoing.
This opinion is reinforced by pharmaceutical companies, who say that the results "emphasize the persistent nature of obesity," similar to managing conditions like diabetes.
User Experiences
People who have stopped the jabs report a sudden resurgence of hunger.
"I experienced a switch activating and you're instantly ravenous," described a patient.
The struggle is compounded if users have not established sustainable dietary or behavioural modifications during treatment.
Significant Adoption
Figures suggest that millions of people in the UK have used these injections in the past year, with demand being substantial.
- Adoption is higher among women than males.
- The middle-aged age group shows the greatest level of interest.
- A large proportion obtain the drugs through private prescriptions rather than the NHS.
Finally, experts caution that while these medications are powerful agents for weight loss, they are not a standalone fix and long-term success hinges on integrated lifestyle support.